November 8, 2023

David L. Blumberg

David L. Blumberg has more than 20 years of business and consulting experience across the life sciences continuum, including global, specialty, and generic pharmaceuticals; biotech; and medical devices and products. Currently, he is the vice president of Global Operations and Portfolio Compliance at Teva Pharmaceuticals.

Previously, Blumberg led the U.S. pharmaceuticals and life sciences advisory practice at KPMG. Prior to that, Blumberg was the executive vice president of professional services and customer support of a public software company that specializes in contract and demand management for life sciences corporations. He spent several years at Accenture, where he served as lead partner for the pharmaceutical and medical products industries and led one of the corporation’s largest account relationships.

Blumberg serves on the board of advisers for the Vagelos Life Sciences and Management Program at the University of Pennsylvania. He has been a guest lecturer at the Wharton School, Harvard Business School, and New York Institute of Technology.

He holds an MBA from the Wharton School and a B.S. in mechanical engineering from Ohio State University.